Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Brimonidine Tartrate

SKU: orb1300783

Description

Brimonidine Tartrate

Research Area

Neuroscience, Pharmacology & Drug Discovery

Images & Validation

Key Properties

CAS Number70359-46-5
MW442.22
Purity99.83% (May vary between batches)
FormulaC15H16BrN5O6
SMILESO[C@H]([C@@H](O)C(O)=O)C(O)=O.Brc1c(NC2=NCCN2)ccc2nccnc12
TargetAdrenergic Receptor
SolubilityH2O:56.53 mM;DMSO:16.67 mg/mL (37.7 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.52 mM)

Bioactivity

Target IC50
α2A-adrenoceptor:0.45 nM(EC50)
In Vivo
Brimonidine (0.5/1 mg/kg) reduced progressive ganglion cell loss (26%/15%). At elevated intraocular pressure, the use of Brimonidine significantly protected retinal ganglion cells and prevented further cell loss. Brimonidine injection into the eyes of SD rats increased the number of brain-derived neurotrophic factor-positive retinal ganglion cells from 55% to 166%. Brimonidine prevented further ganglion cell loss after 10 days of elevated IOP.Brimonidine increased immunoreactivity for glial fibrillary acidic protein in the hypertensive retina of attenuated eyes.
In Vitro
Brimonidine (0.5/1 mg/kg) reduced progressive ganglion cell loss (26%/15%). At elevated intraocular pressure, the use of Brimonidine significantly protected retinal ganglion cells and prevented further cell loss. Brimonidine injection into the eyes of SD rats increased the number of brain-derived neurotrophic factor-positive retinal ganglion cells from 55% to 166%. Brimonidine prevented further ganglion cell loss after 10 days of elevated IOP.Brimonidine increased immunoreactivity for glial fibrillary acidic protein in the hypertensive retina of attenuated eyes.

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Brimonidine, Brimonidine Tartrate, AGN 190342, AGN 190342 Tartrate, AGN190342, AGN-190342, AGN190342 (tartrate), AGN190342 tartrate, AGN-190342 Tartrate, Adrenergic Receptor, AdrenergicReceptor, UK14304, UK-14304, UK14304 tartrate, UK-14304 Tartrate, UK 14304, UK 14304 (tartrate), UK 14304 Tartrate, α2A-adrenergic receptor

Similar Products

  • Brimonidine Tartrate [orb1224186]

    >98% (HPLC)

    70359-46-5

    442.22

    C15H16BrN5O6

    100 mg, 500 mg, 1 g
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

100 mg
$ 90.00
500 mg
$ 170.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry